HEADER IMMUNE SYSTEM 20-NOV-07 3BES TITLE STRUCTURE OF A POXVIRUS IFNGBP/IFNG COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERFERON GAMMA; COMPND 3 CHAIN: L; COMPND 4 SYNONYM: IFN-GAMMA, IMMUNE INTERFERON; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: INTERFERON-GAMMA BINDING PROTEIN C4R; COMPND 8 CHAIN: R; COMPND 9 SYNONYM: INTERFERON-GAMMA RECEPTOR; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IFNG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: ECTROMELIA VIRUS; SOURCE 10 ORGANISM_TAXID: 12643; SOURCE 11 GENE: C4R, IFNGR; SOURCE 12 EXPRESSION_SYSTEM: DROSOPHILA MELANOGASTER; SOURCE 13 EXPRESSION_SYSTEM_COMMON: FRUIT FLY; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7227; SOURCE 15 EXPRESSION_SYSTEM_CELL_LINE: S2 KEYWDS ECTROMELIA VIRUS, ORTHOPOXVIRUS, INTERFERON, PROTEIN COMPLEX, KEYWDS 2 ANTIVIRAL DEFENSE, CYTOKINE, GLYCOPROTEIN, RECEPTOR, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR A.A.NUARA,M.R.WALTER REVDAT 8 30-OCT-24 3BES 1 HETSYN REVDAT 7 29-JUL-20 3BES 1 COMPND REMARK SEQADV HETNAM REVDAT 7 2 1 LINK SITE ATOM REVDAT 6 24-JAN-18 3BES 1 AUTHOR REVDAT 5 25-OCT-17 3BES 1 REMARK REVDAT 4 13-JUL-11 3BES 1 VERSN REVDAT 3 24-FEB-09 3BES 1 VERSN REVDAT 2 26-FEB-08 3BES 1 JRNL REVDAT 1 12-FEB-08 3BES 0 JRNL AUTH A.A.NUARA,L.J.WALTER,N.J.LOGSDON,S.I.YOON,B.C.JONES, JRNL AUTH 2 J.M.SCHRIEWER,R.M.BULLER,M.R.WALTER JRNL TITL STRUCTURE AND MECHANISM OF IFN-GAMMA ANTAGONISM BY AN JRNL TITL 2 ORTHOPOXVIRUS IFN-GAMMA-BINDING PROTEIN. JRNL REF PROC.NATL.ACAD.SCI.USA V. 105 1861 2008 JRNL REFN ISSN 0027-8424 JRNL PMID 18252829 JRNL DOI 10.1073/PNAS.0705753105 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 27031 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : R-FREE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1367 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3114 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 237 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3BES COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-DEC-07. REMARK 100 THE DEPOSITION ID IS D_1000045429. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-OCT-06 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27031 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 7.500 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : 0.04900 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): NULL REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): NULL REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.8M NAH2PO4/0.8M KH2PO4 SOLUTIONS, PH REMARK 280 7.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 46.31500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 59.56500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 92.37000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 46.31500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 59.56500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 92.37000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 46.31500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 59.56500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 92.37000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 46.31500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 59.56500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 92.37000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: OCTAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 45680 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, R, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 92.63000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 119.13000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -1.000000 0.000000 0.000000 92.63000 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 350 BIOMT1 4 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 0.000000 -1.000000 0.000000 119.13000 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 16970 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, R, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 92.63000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 119.13000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11080 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: L REMARK 350 BIOMT1 1 -1.000000 0.000000 0.000000 46.31500 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 -59.56500 REMARK 350 BIOMT3 1 0.000000 0.000000 -1.000000 92.37000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -46.31500 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 59.56500 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 92.37000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: R, A REMARK 350 BIOMT1 3 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 4 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 P PO4 R 1 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN L 133 REMARK 465 MET L 134 REMARK 465 LEU L 135 REMARK 465 PHE L 136 REMARK 465 ARG L 137 REMARK 465 GLY L 138 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS L 61 0.88 -69.87 REMARK 500 GLU R 61 154.40 -49.26 REMARK 500 HIS R 114 169.18 179.83 REMARK 500 GLU R 192 -163.24 58.10 REMARK 500 REMARK 500 REMARK: NULL DBREF 3BES L 1 138 UNP P01579 IFNG_HUMAN 24 161 DBREF 3BES R 17 266 UNP Q66793 Q66793_9POXV 17 266 SEQADV 3BES MET L 0 UNP P01579 INITIATING METHIONINE SEQRES 1 L 139 MET GLN ASP PRO TYR VAL LYS GLU ALA GLU ASN LEU LYS SEQRES 2 L 139 LYS TYR PHE ASN ALA GLY HIS SER ASP VAL ALA ASP ASN SEQRES 3 L 139 GLY THR LEU PHE LEU GLY ILE LEU LYS ASN TRP LYS GLU SEQRES 4 L 139 GLU SER ASP ARG LYS ILE MET GLN SER GLN ILE VAL SER SEQRES 5 L 139 PHE TYR PHE LYS LEU PHE LYS ASN PHE LYS ASP ASP GLN SEQRES 6 L 139 SER ILE GLN LYS SER VAL GLU THR ILE LYS GLU ASP MET SEQRES 7 L 139 ASN VAL LYS PHE PHE ASN SER ASN LYS LYS LYS ARG ASP SEQRES 8 L 139 ASP PHE GLU LYS LEU THR ASN TYR SER VAL THR ASP LEU SEQRES 9 L 139 ASN VAL GLN ARG LYS ALA ILE HIS GLU LEU ILE GLN VAL SEQRES 10 L 139 MET ALA GLU LEU SER PRO ALA ALA LYS THR GLY LYS ARG SEQRES 11 L 139 LYS ARG SER GLN MET LEU PHE ARG GLY SEQRES 1 R 250 THR ILE THR SER TYR LYS PHE GLU SER VAL ASN PHE ASP SEQRES 2 R 250 SER LYS ILE GLU TRP THR GLY ASN GLY LEU TYR ASN ILE SEQRES 3 R 250 SER LEU ARG ASN TYR GLY ILE LYS THR TRP GLN THR MET SEQRES 4 R 250 TYR THR ASN VAL PRO GLU GLY THR TYR ASP ILE SER GLY SEQRES 5 R 250 PHE PRO ASN ASN ASP PHE VAL SER PHE TRP VAL LYS PHE SEQRES 6 R 250 GLU GLN GLY ASP TYR LYS VAL ASP LYS TYR CYS THR GLY SEQRES 7 R 250 LEU CYS ILE GLU VAL LYS ILE GLY PRO PRO THR VAL THR SEQRES 8 R 250 LEU THR GLU TYR ASP ASP HIS ILE ASN LEU TYR ILE GLU SEQRES 9 R 250 HIS PRO TYR ALA THR ARG GLY SER LYS LYS ILE PRO ILE SEQRES 10 R 250 TYR LYS ARG ASN ASP MET CYS ASP ILE TYR LEU LEU TYR SEQRES 11 R 250 THR ALA ASN PHE THR PHE GLY ASP SER GLU GLU PRO VAL SEQRES 12 R 250 ILE TYR ASP ILE ASP ASP TYR ASP CYS THR SER THR GLY SEQRES 13 R 250 CYS SER ILE ASP PHE ALA THR THR GLU LYS VAL CYS VAL SEQRES 14 R 250 MET ALA GLN GLY ALA THR GLU GLY LEU LEU ASP LYS ILE SEQRES 15 R 250 THR PRO TRP SER SER GLU VAL CYS LEU THR PRO LYS LYS SEQRES 16 R 250 ASN VAL TYR THR CYS ALA ILE ARG SER LYS GLU ASP VAL SEQRES 17 R 250 PRO ASN PHE LYS GLU LYS MET THR ARG VAL ILE LYS ARG SEQRES 18 R 250 LYS PHE ASN LYS GLN SER HIS SER TYR LEU THR LYS PHE SEQRES 19 R 250 LEU GLY SER THR SER ASN ASP ILE THR THR PHE LEU SER SEQRES 20 R 250 MET LEU ASP MODRES 3BES ASN R 41 ASN GLYCOSYLATION SITE MODRES 3BES ASN R 149 ASN GLYCOSYLATION SITE HET NAG A 1 14 HET NAG A 2 14 HET BMA A 3 11 HET PO4 L 139 5 HET NAG R 270 14 HET PO4 R 1 5 HET PO4 R 3 5 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM PO4 PHOSPHATE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 3 NAG 3(C8 H15 N O6) FORMUL 3 BMA C6 H12 O6 FORMUL 4 PO4 3(O4 P 3-) FORMUL 8 HOH *237(H2 O) HELIX 1 1 GLN L 1 PHE L 15 1 15 HELIX 2 2 HIS L 19 ASP L 24 5 6 HELIX 3 3 PHE L 29 TRP L 36 1 8 HELIX 4 4 GLU L 38 ASN L 59 1 22 HELIX 5 5 ILE L 66 PHE L 81 1 16 HELIX 6 6 ASN L 85 TYR L 98 1 14 HELIX 7 7 ASP L 102 SER L 121 1 20 HELIX 8 8 PRO L 122 THR L 126 5 5 HELIX 9 9 GLY R 94 VAL R 99 1 6 HELIX 10 10 ARG R 136 CYS R 140 5 5 HELIX 11 11 ASP R 164 CYS R 168 5 5 HELIX 12 12 SER R 220 GLU R 222 5 3 HELIX 13 13 ASP R 223 PHE R 239 1 17 HELIX 14 14 ASN R 240 MET R 264 1 25 SHEET 1 A 3 ILE R 18 VAL R 26 0 SHEET 2 A 3 ASP R 29 GLY R 36 -1 O LYS R 31 N GLU R 24 SHEET 3 A 3 GLY R 62 ASP R 65 -1 O TYR R 64 N ILE R 32 SHEET 1 B 4 GLN R 53 VAL R 59 0 SHEET 2 B 4 TYR R 40 ASN R 46 -1 N ILE R 42 O MET R 55 SHEET 3 B 4 PHE R 77 GLN R 83 -1 O LYS R 80 N SER R 43 SHEET 4 B 4 TYR R 86 CYS R 92 -1 O LYS R 90 N VAL R 79 SHEET 1 C 3 THR R 105 TYR R 111 0 SHEET 2 C 3 HIS R 114 GLU R 120 -1 O GLU R 120 N THR R 105 SHEET 3 C 3 GLY R 172 PHE R 177 -1 O PHE R 177 N ILE R 115 SHEET 1 D 2 TYR R 123 ARG R 126 0 SHEET 2 D 2 LYS R 129 PRO R 132 -1 O ILE R 131 N ALA R 124 SHEET 1 E 4 VAL R 159 ASP R 162 0 SHEET 2 E 4 LEU R 145 PHE R 152 -1 N PHE R 150 O VAL R 159 SHEET 3 E 4 VAL R 183 ALA R 190 -1 O CYS R 184 N THR R 151 SHEET 4 E 4 VAL R 205 LEU R 207 -1 O VAL R 205 N VAL R 185 SSBOND 1 CYS R 96 CYS R 140 1555 1555 2.03 SSBOND 2 CYS R 168 CYS R 173 1555 1555 2.04 SSBOND 3 CYS R 184 CYS R 206 1555 1555 2.04 SSBOND 4 CYS R 216 CYS R 216 1555 3655 2.24 LINK ND2 ASN R 41 C1 NAG A 1 1555 1555 1.45 LINK ND2 ASN R 149 C1 NAG R 270 1555 1555 1.45 LINK O4 NAG A 1 C1 NAG A 2 1555 1555 1.38 LINK O4 NAG A 2 C1 BMA A 3 1555 1555 1.39 CRYST1 92.630 119.130 184.740 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010796 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008394 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005413 0.00000